Publication | Open Access

A phase 1b dose escalation study of ipafricept (OMP 54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

Phase 1BOmp 54F28OncologyMedicineGynecologyDose Escalation StudyCancer TreatmentPharmacologyGynecology OncologyEndocrine-related CancerOvarian Cancer